»Go to related Japanese page in JPubb
»Go to "Pharmaceuticals" Company Directory


Loading

Press Releases from "Pharmaceuticals" Non-listed Companies

« Previous1234Next »
1 - 50 of 172 for your search
Acucela and Otsuka Pharmaceutical Announce Phase IIa Clinical Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting
[ Otsuka Pharmaceutical Co., Ltd. | 2013-05-09]
Otsuka Pharmaceutical’s 44-member Employee Dance Group “Otsuka-Ren” Presented Traditional “Awa-Odori” of Tokushima, Where the Company Originates From, At Copenhagen Sakura Festival Held in Denmark
[ Otsuka Pharmaceutical Co., Ltd. | 2013-04-30]
“Epi Diary” – An Epilepsy Diary Application for iOS, A New Communication Tool for Patients with Epilepsy and their Physicians, Now Available at https://itunes.apple.com/app/epi-diary/ id616736809?Is=1＆mt=8
[ Otsuka Pharmaceutical Co., Ltd. | 2013-04-17]
Otsuka’s New Drug Application For Tolvaptan, An Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted For Review By The US Food And Drug Administration (FDA)
[ Otsuka Pharmaceutical Co., Ltd. | 2013-04-12]
Otsuka’s New Drug Application For Tolvaptan, The Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted For Review By The US Food And Drug Administration (FDA)
[ Otsuka Pharmaceutical Co., Ltd. | 2013-04-12]
Otsuka’s New Drug Application For Tolvaptan, The Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Acceped For Review By The Us Food And Drug Administration (FDA)
[ Otsuka Pharmaceutical Co., Ltd. | 2013-04-12]
New Version of Pocari Sweat, Low calorie beverage with subtle sweetness, refreshing after-taste, Pocari Sweat Ion Water, Debuts April 8, 2013
[ Otsuka Pharmaceutical Co., Ltd. | 2013-04-04]
Like Having Everything At Your Fingertips? Then Check This Out! Otsuka Pharmaceutical Announces A Revamped Website, April 1, 2013, http://www.otsuka.co.jp/
[ Otsuka Pharmaceutical Co., Ltd. | 2013-04-01]
Otsuka’s Novel Treatment for Multidrug-Resistant Tuberculosis, Delamanid, Filed in Japan After Half-A-Century Since Last Drug Approval for Tuberculosis
[ Otsuka Pharmaceutical Co., Ltd. | 2013-03-27]
Lundbeck and Otsuka Further Expand Alliance and Enter Into Collaboration For the Development and Commercialization of Lu AE58054 In Development For Alzheimer’s Disease
[ Otsuka Pharmaceutical Co., Ltd. | 2013-03-26]
Otsuka Obtains Marketing Approval in Japan for OnglyzaⓇ Tablets to Treat Type 2 Diabetes; Transferred Rights to Kyowa Hakko Kirin
[ Otsuka Pharmaceutical Co., Ltd. | 2013-03-25]
“Weight Management with Chocolate”, White Chocolate and Orange Chocolate, Gerlinéa Meal Replacement Bars Debut on March 18
[ Otsuka Pharmaceutical Co., Ltd. | 2013-03-14]
“Weight Management with Chocolate” White Chocolate and Orange Chocolate Gerlinéa Meal Replacement Bars Debut on March 18
[ Otsuka Pharmaceutical Co., Ltd. | 2013-03-14]
The healthy benefits of whole soy flavored with crunchy peanuts, SOYJOY Peanuts Debuts April 24
[ Otsuka Pharmaceutical Co., Ltd. | 2013-03-13]
The healthy benefits of whole soy flavored with crunchy peanuts SOYJOY Peanuts Debuts April 24
[ Otsuka Pharmaceutical Co., Ltd. | 2013-03-13]
Otsuka Advancing Rapidly in Central Nervous System Disorders; Expanding Its Existing Collaboration with Lundbeck
[ Otsuka Pharmaceutical Co., Ltd. | 2013-03-07]
The First Transdermal Dopamin Agonist in Japan Neupro® Patch, For Both Parkinson’s Disease and Restless Legs Syndrome, To Be Launched on February 26
[ Otsuka Pharmaceutical Co., Ltd. | 2013-02-22]
L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms for Carnitine Deficiency To Be Launched on February 26
[ Otsuka Pharmaceutical Co., Ltd. | 2013-02-22]
Otsuka Pharmaceutical Contributes to the Success and Development of the Tokyo Marathon as a Total Health Care Company Supporting Safe Running and Encouraging Runners to Complete the Full Distance with Amino Acids, Fluids and Electrolytes
[ Otsuka Pharmaceutical Co., Ltd. | 2013-02-20]
7.5mg Tablets Additionally Approved - Samsca®, Vasopressin V2 Receptor Antagonist
[ Otsuka Pharmaceutical Co., Ltd. | 2013-02-08]
The European Medicines Agency (EMA) Approves Aripiprazole (ABILIFY®) for the Treatment of Moderate to Severe Manic Episodes in Bipolar I Disorder in Adolescents.
[ Otsuka Pharmaceutical Co., Ltd. | 2013-02-06]
FDA Approves Once-Monthly ABILIFY MAINTENA™ (Aripiprazole) For Extended-Release Injectable Suspension for the Treatment of Schizophrenia
[ Otsuka Pharmaceutical Co., Ltd. | 2013-02-01]
UL・OS Line of Men’s Skincare Launches New SPF 50 & SPF 25 Sunscreens Applies Smoothly, Leaves No White Residue
[ Otsuka Pharmaceutical Co., Ltd. | 2013-01-28]
Otsuka Pharmaceutical Files for Application of New Dry Powder Inhaler Product from the Meptin Brand
[ Otsuka Pharmaceutical Co., Ltd. | 2013-01-11]
French subsidiary Nutrition & Santé acquires gluten-free nutrition company from Lactalis Group
[ Otsuka Pharmaceutical Co., Ltd. | 2013-01-09]
Otsuka and Lundbeck initiate the regulatory process for aripiprazole (once-monthly) depot formulation in Europe
[ Otsuka Pharmaceutical Co., Ltd. | 2012-12-25]
L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms approved for Carnitine Deficiency
[ Otsuka Pharmaceutical Co., Ltd. | 2012-12-25]
The World’s Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson’s Disease and Restless Legs Syndrome
[ Otsuka Pharmaceutical Co., Ltd. | 2012-12-25]
Announcement; Launch of 5-HT3 Receptor Antagonist Aloxi® I.V. infusion bag 0.75mg
[ Taiho Pharmaceutical Co., Ltd. | 2012-11-30]
Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceutical Will Continue to Support Safe Running and Encourage Runners to Complete the Full Distance
[ Otsuka Pharmaceutical Co., Ltd. | 2012-11-20]
Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceutical Will Continue to Support Safe Running and Encourage Runners to Complete the Full Distance
[ Otsuka Pharmaceutical Co., Ltd. | 2012-11-20]
Otsuka Pharmaceutical and Abdi İbrahim Established a Joint Venture Company for Pharmaceutical Sales in Turkey
[ Otsuka Pharmaceutical Co., Ltd. | 2012-11-06]
Otsuka Pharmaceutical Tokushima Itano Factory to Cosponsor Asan Walking Festival in Itano A Portion of Entry Fees to be Donated to Great East Japan Earthquake Relief Efforts
[ Otsuka Pharmaceutical Co., Ltd. | 2012-11-05]
Otsuka’s Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
[ Otsuka Pharmaceutical Co., Ltd. | 2012-11-05]
Kenja no Shokutaku Double Support Food for Specified Health Use with Dual Function Suppressing the Absorption of Both Sugars and Lipids, to Launch in Japan for the First Time
[ Otsuka Pharmaceutical Co., Ltd. | 2012-10-29]
Super Vitamin D, Containing the Daily Optimum Dose of Vitamin D in One Single Tablet Launched from Nature Made® - America’s Number One Dietary Supplement Brand
[ Otsuka Pharmaceutical Co., Ltd. | 2012-10-01]
ZOSYN®, an Injectable Antibiotic Combination Product Receives an Approval for Peritonitis, Intra-abdominal Abscess, Cholecystitis, and Cholangitis
[ Taiho Pharmaceutical Co., Ltd. | 2012-09-28]
New “Poppy Seed ＆ Lemon” from Gerblé to launch on October 15 The No.1 French Health Food Brand now in 3,000 stores nationwide
[ Otsuka Pharmaceutical Co., Ltd. | 2012-09-24]
Clinical Trial (JASPAC 01) of TS-1 for Resected Pancreatic Cancer
[ Taiho Pharmaceutical Co., Ltd. | 2012-09-18]
Kyowa Hakko Kirin Returns to Otsuka Pharmaceutical the Rights to Develop and Market Busulfex®, for Use As a Part of Conditioning Regimen Prior to Hematopoietic Progenitor Cell Transplantation, in Japan and in Asian Countries ＆ Regions
[ Otsuka Pharmaceutical Co., Ltd. | 2012-09-14]
ABILIFY® ,The First Antipsychotic Agent in Japan Applying for Adjunctive Treatment in Major Depressive Disorder
[ Otsuka Pharmaceutical Co., Ltd. | 2012-09-03]
Otsuka, the First Pharmaceutical Company in Japan to Have Been Certified for “ISO22301”, the International Standard for Business Continuity Management
[ Otsuka Pharmaceutical Co., Ltd. | 2012-08-29]
Results of a Phase II Clinical Trial for the Novel Antitumor Agent TAS-102 Posted on the Electronic Edition of The Lancet Oncology
[ Taiho Pharmaceutical Co., Ltd. | 2012-08-28]
Vasopressin V2-Receptor Antagonist, Samsca® Tablets were filed Additional Indication of the Treatment of Fluid Retention Associated with Cirrhosis of the Liver
[ Otsuka Pharmaceutical Co., Ltd. | 2012-08-01]
Pocari Sweat Launches in Vietnam through New Joint Venture Company. Vietnam Launch is the17th Market in the World Where the Pocari Sweat is Sold
[ Otsuka Pharmaceutical Co., Ltd. | 2012-08-01]
Taiho and Faes Farma (Spain) Enter into a License Agreement on Anti-Allergy Agent
[ Taiho Pharmaceutical Co., Ltd. | 2012-07-24]
Proteus Digital Health, Inc. and Otsuka Pharmaceutical Co., Ltd. Announce Worldwide Agreement to Develop Novel Digital Health Products
[ Otsuka Pharmaceutical Co., Ltd. | 2012-07-06]
Otsuka Pharmaceutical × Nakacho, Tokushima Prefecture Largest Free Live Music Concert in Japan to Be Held
[ Otsuka Pharmaceutical Co., Ltd. | 2012-06-30]
Otsuka Pharmaceutical and Kyowa Hakko Kirin announce strategic alliance in the fields of diabetes and oncology
[ Otsuka Pharmaceutical Co., Ltd. | 2012-06-29]
Reverse Daylight Savings Program to Shift Peak Energy Consumption
[ Otsuka Pharmaceutical Co., Ltd. | 2012-06-26]
« Previous1234Next »


Press Conferense Videos
Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays
Sharp Corporation 2012/06/01
More Videos
Latest Press Release Search

Save favorite searches Hot keywords

Fukushima | power supply | cloud | solar
*NOTE: Recommended keywords shown above.
Your Most Recently Viewed Companies
Visit any of the company pages in JPubb, and your most recently viewed companies will automatically show up here.

Erase all This feature:ON How to use
Most Popular: Pharmaceuticals
1. JT and Torii Pharmaceutical to Launch New HIV Treatment Drugs in Japan
Torii Pharmaceutical Co., Ltd. 2005/04/08
2. Roche Reports Second Positive Study of RoACTEMRA Given by
Chugai Pharmaceutical Co., Ltd. 2012/07/27
3. Notice concerning acquisition result and acquisition end of companyfs own shares. (Acquisition of companyfs own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)
Hisamitsu Pharmaceutical Co., Inc. 2009/12/11
4. In-vitro Diagnostic Kit, WT1 mRNA Assay Kit 'Otsuka' Received Regulatory Approval for Additional Purpose of Use with Myelodysplastic Syndromes
Otsuka Pharmaceutical Co., Ltd. 2011/02/16
5. Daiichi Sankyo Appoints New Board Position at each Subsidiary
Daiichi Sankyo Company, Limited 2010/02/26
Feed
Releases by Prefecture
Hokkaido | Aomori | Iwate | Miyagi | Akita | Yamagata | Fukushima

Ibaraki | Tochigi | Gunma | Saitama | Chiba | Tokyo | Kanagawa

Niigata | Toyama | Ishikawa | Fukui | Yamanashi | Nagano

Gifu | Shizuoka | Aichi | Mie

Shiga | Kyoto | Osaka | Hyogo | Nara | Wakayama

Tottori | Shimane | Okayama | Hiroshima | Yamaguchi

Tokushima | Kagawa | Ehime | Kochi

Fukuoka | Saga | Nagasaki | Kumamoto | Oita | Miyazaki | Kagoshima | Okinawa
Releases by Stock Exchange
TSE (Tokyo) All | TSE1 | TSE2 | Mothers

OSE (Osaka) All | OSE1 | OSE2 | JASDAQ Standard | JASDAQ Growth

NSE (Nagoya) All | NSE1 | NSE2 | Centrex | NSE-only

SSE (Sapporo) All | Ambitious | SSE-only

FSE (Fukuoka) All | Q-Board | FSE-only
Press Release Search
Company
Industry
Prefecture
Stock Exchange
Date
(yyyy/mm/dd)		 //～
//
Listed or Non-listed
*NOTE: Please input only items to be specified.
*NOTE: The "date" here means the one on which a press release is uploaded on this website. So it isn't necessarily the same as its official announcement date.
Company Search
Company
Industry
Prefecture
Stock Exchange
Listed or Non-listed
*NOTE: Please input only items to be specified.